Tilray Brands, Inc. (NASDAQ:TLRY) is one of the stocks Jim Cramer was asked about. When a caller asked about the stock during the lightning round, Cramer stated:
“It’s a kaching kaching. I want you to sell half, and if they approve it, then you sell the other half. You see, because what they lack is earnings.”
Copyright: atomazul / 123RF Stock Photo
Tilray Brands, Inc. (NASDAQ:TLRY) produces and sells medical and adult-use cannabis, beverages, hemp-based foods, and wellness products. On December 11, the company announced the introduction of Amped Live Resin Liquid Diamond 1g 510 cartridges, Redecan’s (a brand Tilray acquired in 2023 through the acquisition of HEXO Corp.) first live resin–liquid diamond line. The launch includes Space Age CK and Blueberry DNTS, which are made with 80% Legit Live Resin and 20% Liquid Diamonds. The announcement also highlighted that Live Resin Vapes have grown 6.3% in the past six months, with Liquid Diamond products among Canada’s top-selling vapes.
While we acknowledge the potential of TLRY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
